NL
BEAM icon

NVWM LLC’s Beam Therapeutics BEAM Stock Holding History

NVWM LLC’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,959
Closed -$570K – 469
2022
Q1 		$570K Sell
9,959
-106
-1% -$6.95K 0.18% 156
2021
Q4 		$802K Buy
10,065
+475
+5% +$40.7K 0.25% 143
2021
Q3 		$834K Buy
9,590
+9,460
+7,277% +$950K 0.3% 136
2021
Q2 		$17K Buy
+130
New +$10.4K 0.01% 301

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

NVWM LLC's BEAM Position: Q2 2022 in Review

NVWM LLC sold out of Beam Therapeutics (BEAM) in Q2 2022, closing a stake of 9,959 shares — an estimated $570K sold.

NVWM LLC first reported a position in BEAM in Q2 2021 and held it in 4 quarters. The position peaked at $834K in Q3 2021. 205 funds tracked by Wall St. Rank hold BEAM as of Q2 2022.

  • NVWM LLC reported no remaining Beam Therapeutics position as of Q2 2022 after selling out during the quarter.
  • NVWM LLC sold 9,959 Beam Therapeutics shares in Q2 2022, an estimated $570K.
  • NVWM LLC first reported a position in Beam Therapeutics in Q2 2021 and held it in 4 quarters.
  • NVWM LLC's Beam Therapeutics position peaked at $834K in Q3 2021.
  • 205 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2022.

Based on NVWM LLC's 13F filing for Q2 2022, filed 4 Aug 2022.